Fracture risk and adjuvant therapies in young breast cancer patients: a population-based study.
about
Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO IMS, and SIOGDifferences in responses to X-ray exposure between osteoclast and osteoblast cells.Vertebral fractures among breast cancer survivors in China: a cross-sectional study of prevalence and health services gaps.
P2860
Fracture risk and adjuvant therapies in young breast cancer patients: a population-based study.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Fracture risk and adjuvant the ...... nts: a population-based study.
@ast
Fracture risk and adjuvant the ...... nts: a population-based study.
@en
type
label
Fracture risk and adjuvant the ...... nts: a population-based study.
@ast
Fracture risk and adjuvant the ...... nts: a population-based study.
@en
prefLabel
Fracture risk and adjuvant the ...... nts: a population-based study.
@ast
Fracture risk and adjuvant the ...... nts: a population-based study.
@en
P2093
P2860
P1433
P1476
Fracture risk and adjuvant the ...... nts: a population-based study.
@en
P2093
Chieh-Yu Liu
Chun-Hung Chang
Shaw-Ji Chen
P2860
P304
P356
10.1371/JOURNAL.PONE.0130725
P407
P577
2015-06-24T00:00:00Z